Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 11,237 $ 13,118
Premium and trade receivables 16,169 12,238
Short-term investments 1,668 1,539
Other current assets 2,036 1,602
Total current assets 31,110 28,497
Long-term investments 14,129 14,043
Restricted deposits 1,210 1,068
Property, software and equipment, net 3,583 3,391
Goodwill 20,903 19,771
Intangible assets, net 8,138 7,824
Other long-term assets 3,828 3,781
Total assets 82,901 78,375
Current liabilities:    
Medical claims liability 16,259 14,243
Accounts payable and accrued expenses 9,980 8,493
Return of premium payable 2,628 2,328
Unearned revenue 526 434
Current portion of long-term debt 292 267
Total current liabilities 29,685 25,765
Long-term debt 18,640 18,571
Deferred tax liability 1,292 1,407
Other long-term liabilities 5,854 5,610
Total liabilities 55,471 51,353
Commitments and contingencies
Redeemable noncontrolling interests 117 82
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 605,925 issued and 584,854 outstanding at March 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 1 1
Additional paid-in capital 19,830 19,672
Accumulated other comprehensive earnings (485) 77
Retained earnings 8,988 8,139
Treasury stock, at cost (21,071 and 20,225 shares, respectively) (1,165) (1,094)
Total Centene stockholders’ equity 27,169 26,795
Nonredeemable noncontrolling interest 144 145
Total stockholders’ equity 27,313 26,940
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 82,901 $ 78,375